Molecular biology, pathogenesis and pathology of mumps virus

Journal of Pathology

Volumn 235, Issue 2, 2015, Pages 242-252

  Rubin, Steven ^a   Eckhaus, Michael ^b   Rennick, Linda J ^d   Bamford, Connor G G ^c   Duprex, W Paul ^d  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mumps; Mumps virus; Neurovirulence; Pathogenesis; Vaccine

Indexed keywords

ARTICLE; ASEPTIC MENINGITIS; ASYMPTOMATIC INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; HUMAN; MOLECULAR BIOLOGY; MUMPS; MUMPS VIRUS; NONHUMAN; ORCHITIS; PARAMYXOVIRUS; PAROTITIS; VACCINATION; VIRUS PATHOGENESIS; ANIMAL; BIOPSY; DISEASE MODEL; GENETICS; GENOTYPE; HOST PATHOGEN INTERACTION; MOLECULAR PATHOLOGY; PATHOGENICITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; VIROLOGY; VIRULENCE;

MUMPS VACCINE;

ANIMALS; BIOPSY; DISEASE MODELS, ANIMAL; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; MUMPS; MUMPS VACCINE; MUMPS VIRUS; PATHOLOGY, MOLECULAR; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VIROLOGY; VIRULENCE;

EID: 84917707316     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4445     Document Type: Article

References (169)

1. Wagenvoort JH, Harmsen M, Boutahar-Trouw BJ, et al. Epidemiology of mumps in The Netherlands. J Hyg (Lond) 1980; 85: 313-326.
2. Anderson RM, Crombie JA, Grenfell BT. The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization. Epidemiol Infect 1987; 99: 65-84.
3. Cox MJ, Anderson RM, Bundy DA, et al. Seroepidemiological study of the transmission of the mumps virus in St. Lucia, West Indies. Epidemiol Infect 1989; 102: 147-160.
4. Centers for Disease Control and Prevention. Current trends mumps-United States, 1984-1985. Morb Mortal Wkly Rep 1986; 35: 216-219.
5. McNabb SJ, Jajosky RA, Hall-Baker PA, et al. Summary of notif-able diseases-United States, 2005. Morb Mortal Wkly Rep 2007; 54: 1-92.
6. Boxall N, Kubinyiova M, Prikazsky V, et al. An increase in the number of mumps cases in the Czech Republic, 2005-2006. Eurosurveillance 2008; 13: Article 8.
7. Bangor-Jones RD, Dowse GK, Giele CM, et al. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimber-ley region of Western Australia. Med J Aust 2009; 191: 398-401.
8. Park DW, Nam MH, Kim JY, et al. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine 2007; 25: 4665-4670.
9. Centers for Disease Control and Prevention. Mumps epidemic-United Kingdom, 2004-2005. Morb Mortal Wkly Rep 2006; 55: 173-175.
10. Watson-Creed G, Saunders A, Scott J, et al. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. Can Med Assoc J 2006; 175: 483-488.
11. Schmid D, Pichler AM, Wallenko H, et al. Mumps outbreak affecting adolescents and young adults in Austria, 2006. Eurosurveillence 2006; 11: E060615.
12. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358: 1580-1589.
13. Sartorius B, Penttinen P, Nilsson J, et al. An outbreak of mumps in Sweden, February-April 2004. Eurosurveillence 2005; 10: 191-193.
14. Vandermeulen C, Roelants M, Vermoere M, et al. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 2004; 22: 2713-2716.
15. Castilla J, Garcia CM, Barricarte A, et al. Mumps outbreak in Navarre region, Spain, 2006-2007. Eurosurveillence 2007; 12: E070215.
16. Centers for Disease Control and Prevention. Brief report: update: mumps activity-United States, January 1-October 7, 2006. Morb Mortal Wkly Rep 2006; 55: 1152-1153.
17. Cortese MM, Jordan HT, Curns AT, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008; 46: 1172-1180.
18. Marin M, Quinlisk P, Shimabukuro T, et al. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine 2008; 26: 3601-3607.
19. Roberts C, Porter-Jones G, Crocker J, et al. Mumps outbreak on the island of Anglesey, North Wales, December 2008-January 2009. Eurosurveillence 2009; 14: Article 1.
20. Rota JS, Turner JC, Yost-Daljev MK, et al. Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol 2009; 81: 1819-1825.
21. Nagai T, Okafuji T, Miyazaki C, et al. A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan. Vaccine 2007; 25: 2742-2747.
22. Baba K, Okuno Y, Tanaka-Taya K, et al. Immunization coverage and natural infection rates of vaccine-preventable diseases among children by questionnaire survey in 2005 in Japan. Vaccine 2011; 29: 3089-3092.
23. Litman N, Baum SG. Mumps Virus. In Principles and Practice of Infectious Diseases, 7th edn, Mandell GL, Bennett JE, Donlin R (eds). Churchill Livingstone: Philadelphia, PA, 2010; 2201-2206.
24. Johnson CD, Goodpasture EW. An investigation of the etiology of mumps. J Exp Med 1934; 59: 1-19.
25. Johnson CD, Goodpasture EW. The etiology of mumps. Am J Hyg 1935; 21: 46-57.
26. Elango N, Varsanyi TM, Kovamees J, et al. Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Vi ro l 1988; 69: 2893-2900.
27. Elliott GD, Yeo RP, Afzal MA, et al. Strain-variable editing during transcription of the P gene of mumps virus may lead to the generation of non-structural proteins NS1 (V) and NS2. J Gen Vi ro l 1990; 71: 1555-1560.
28. Li M, Schmitt PT, Li Z, et al. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for effcient production of virus-like particles. J Virol 2009; 83: 7261-7272.
29. Harrison MS, Sakaguchi T, Schmitt AP. Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol 2010; 42: 1416-1429.
30. He B, Leser GP, Paterson RG, et al. The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology 1998; 250: 30-40.
31. He B, Lin GY, Durbin JE, et al. The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol 2001; 75: 4068-4079.
32. Malik T, Shegogue CW, Werner K, et al. Discrimination of mumps virus small hydrophobic gene deletion effects from gene translation effects on virus virulence. J Virol 2011; 85: 6082-6085.
33. Paterson RG, Lamb RA. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol 1990; 64: 4137-4145.
34. Andrejeva J, Childs KS, Young DF, et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-ß promoter. Proc Natl Acad Sci USA 2004; 101: 17264-17269.
35. Puri M, Lemon K, Duprex WP, et al. A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting. J Virol 2009; 83: 6347-6356.
36. Kubota T, Yokosawa N, Yokota S, et al. C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon-a and-y signal transduction pathway through decrease of STAT 1-a. Biochem Biophys Res Commun 2001; 283: 255-259.
37. Henle G, Henle W, Wendell K, et al. Isolation of mumps virus from human being with induced apparent or inapparent infections. J Exp Med 1948; 88: 223-232.
38. Foy HM, Cooney MK, Hall CE, et al. Isolation of mumps virus from children with acute lower respiratory tract disease. Am J Epidemiol 1971; 94: 467-472.
39. Zajac BA, Henle W, Henle G. The effect of mumps virus on the resistance of Burkitt lymphoma cell lines to various viruses. Cancer Res 1969; 29: 481-488.
40. Lemon K, de Vries RD, Mesman AW, et al. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 2011; 7: e1001263.
41. Kilham L. Isolation of mumps virus from the blood of a patient. Proc Soc Exp Biol Med 1948; 69: 99-100.
42. Overman JR. Viremia in human mumps virus infections. Arch Intern Med 1958; 102: 354-356.
43. Mishra B, Pujhari SK, Dhiman V, et al. Genotyping and subtyping of mumps virus isolates from the Indian subcontinent. Arch Virol 2013; 158: 2359-2363.
44. Wolinsky JS, Klassen T, Baringer JR. Persistance of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis 1976; 133: 260-267.
45. Reed D, Brown G, Merrick R, et al. A mumps epidemic on St. George Island, Alaska. J Am Med Assoc 1967; 199: 113-117.
46. Philip RN, Reinhard KP, Lachman DB. Observations on a mumps epidemic in a 'virgin' population. Am J Hyg 1959; 69: 91-111.
47. Brunell PA, Brickman A, O'Hare D, et al. Ineffectiveness of isolation of patients as a method of preventing the spread of mumps. Failure of the mumps skin-test antigen to predict immune status. N Engl J Med 1968; 279: 1357-1361.
48. Falk WA, Buchan K, Dow M, et al. The epidemiology of mumps in southern Alberta, 1980-1982. Am J Epidemiol 1989; 130: 736-749.
49. Cooney MK, Fox JP, Hall CE. The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfuenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Am J Epidemiol 1975; 101: 532-551.
50. Hope-Simpson RE. Infectiousness of comminicable diseases in the household (measles, chickenpox, and mumps). Lancet 1952; 2: 549-554.
51. Henle G, Enders JF. Mumps virus. In Viral and Rickettsial Infections of Man, Horstfall F, Tamm I (eds). Lippincott: Philadelphia, PA, 1965; 755-768.
52. Weller TH, Craig JR. Isolation of mumps virus at autopsy. Am J Pathol 1949; 25: 1105-1115.
53. Scully C, Eckersall PD, Emond RT, et al. Serum α-amylase isozymes in mumps: estimation of salivary and pancreatic isozymes by isoelectric focusing. Clin Chim Acta 1981; 113: 281-291.
54. Chiba Y, Horino K, Umetsu M, et al. Virus excretion and antibody response in saliva in natural mumps. Tohoku J Exp Med 1973; 111: 229-238.
55. Ennis FA, Jackson D. Isolation of virus during the incubation period of mumps infection. J Pediatr 1968; 72: 536-537.
56. Postovit VA. [Epidemic parotitis in adults]. Vo e n Med Zh 1983; 3: 38-41.
57. McGuiness AC, Gall EA. Mumps at army camps in 1943. War Med 1944; 5: 95-104.
58. Bjorvatn B. Mumps virus recovered from testicles by fne-needle aspiration biopsy in cases of mumps orchitis. Scand J Infect Dis 1973; 5: 3-5.
59. Jalal H, Bahadur G, Knowles W, et al. Mumps epididymo-orchitis with prolonged detection of virus in semen and the development of anti-sperm antibodies. J Med Virol 2004; 73: 147-150.
60. Clifford V, Wadsley J, Jenner B, et al. Mumps vaccine associated orchitis: evidence supporting a potential immune-mediated mechanism. Vaccine 2010; 28: 2671-2673.
61. Ternavasio-de la Vega HG, Boronat M, Ojeda A, et al. Mumps orchitis in the post-vaccine era (1967-2009): a single-center series of 67 patients and review of clinical outcome and trends. Medicine (Baltimore) 2010; 89: 96-116.
62. Dejucq N, Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev 2001; 65: 208-231.
63. Le GR, Mouchel T, Ruffault A, et al. Mumps virus decreases testosterone production and γ-interferon-induced protein 10 secretion by human Leydig cells. J Virol 2003; 77: 3297-3300.
64. Candel S. Epididymitis in mumps, including orchitis: further clinical studies and comment. Ann Intern Med 1951; 34: 20.
65. Shulman A, Shohat B, Gillis D, et al. Mumps orchitis among soldiers: frequency, effect on sperm quality, and sperm antibodies. Fertil Steril 1992; 57: 1344-1346.
66. Maynard JE, Shramek G, Noble GR, et al. Use of attenuated live mumps virus vaccine during a 'virgin soil' epidemic of mumps on St. Paul Island, Alaska. Am J Epidemiol 1970; 92: 301-306.
67. Prinz W, Taubert HD. Mumps in pubescent females and its effect on later reproductive function. Gynaecologia 1969; 167: 23-27.
68. Morrison JC, Givens JR, Wiser WL, et al. Mumps oophoritis: a cause of premature menopause. Fertil Steril 1975; 26: 655-659.
69. Utz JP, Szwed CF. Mumps III. Comparison of methods for detection of viruria. Proc Soc Exp Biol Med 1962; 110: 841-844.
70. Utz JP, Houk VN, Alling DW. Clinical and laboratory studies of mumps. IV. Viruria and abnormal renal function. N Engl J Med 1964; 270: 1283-1286.
71. Lin CY, Chen WP, Chiang H. Mumps associated with nephritis. Child Nephrol Urol 1990; 10: 68-71.
72. Kabakus N, Aydinoglu H, Bakkaloglu SA, et al. Mumps interstitial nephritis: a case report. Pe d i atr Nephrol 1999; 13: 930-931.
73. Hughes WT, Steigman AJ, Delong HF. Some implications of fatal nephritis associated with mumps. Am J Dis Child 1966; 111: 297-301.
74. Nishino H, Engel AG, Rima BK. Inclusion body myositis: the mumps virus hypothesis. Ann Neurol 1989; 25: 260-264.
75. Dacou-Voutetakis C, Constantinidis M, Moschos A, et al. Diabetes mellitus following mumps. Insulin reserve. Am J Dis Child 1974; 127: 890-891.
76. Hyoty H, Leinikki P, Reunanen A, et al. Mumps infections in the etiology of type 1 (insulin-dependent) diabetes. Diabetes Res 1988; 9: 111-116.
77. Sultz HA, Hart BA, Zielezny M, et al. Is mumps virus an etiologic factor in juvenile diabetes mellitus. J Pediatr 1975; 86: 654-656.
78. Otten A, Helmke K, Stief T, et al. Mumps, mumps vaccination, islet cell antibodies and the frst manifestation of diabetes mellitus type I. Behring Inst Mitt 1984; 75: 83-88.
79. Goto A, Takahashi Y, Kishimoto M, et al. A case of fulminant type 1 diabetes associated with signifcant elevation of mumps titers. Endocr J 2008; 55: 561-564.
80. Bang HO, Bang J. Involvement of the central nervous system in mumps. Acta Med Scand 1943; 113: 487-505.
81. Brown JW, Kirkland HB, Hein GE. Central nervous system involvement during mumps. Am J Med Sci 1948; 215: 434-441.
82. Bruyn HB, Sexton HM, Brainerd HD. Mumps meningoencephalitis. A clinical review of 119 cases with one death. Calif Med 1957; 86: 153-160.
83. Centers for Disease Control and Prevention. Measles, mumps, and rubella-vaccine use and strategies for the elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid Mortal Weekly Rep 1998; 47: 1-48.
84. Ponka A, Pettersson T. The incidence and aetiology of central nervous system infections in Helsinki in 1980. Acta Neurol Scand 1982; 66: 529-535.
85. Mallewa M, Vallely P, Faragher B, et al. Viral CNS infections in children from a malaria-endemic area of Malawi: a prospective cohort study. Lancet Glob Health 2013; 1: e153-160.
86. Azimi PH, Cramblett HG, Haynes RE. Mumps meningoencephalitis in children. J Am Med Assoc 1969; 207: 509-512.
87. Kilham L. Mumps meningoencephalitis with and without parotitis. Am J Dis Child 1949; 78: 324-333.
88. Takano T, Mekata Y, Yamano T, et al. Early ependymal changes in experimental hydrocephalus after mumps virus inoculation in hamsters. Acta Neuropathol 1993; 85: 521-525.
89. Johnson RT, Johnson KP, Edmonds CJ. Virus-induced hydro-cephalus: development of aqueductal stenosis in hamsters after mumps infection. Science 1967; 157: 1066-1067.
90. Johnson RT, Johnson KP. Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol 1968; 27: 591-606.
91. Wolinsky JS, Baringer JR, Margolis G, et al. Ultrstructureof mumps virus replication in newborn hamster central nervous system. Lab Invest 1974; 31: 403-412.
92. London WT, Kent SG, Palmer AE, et al. Induction of congenital hydrocephalus with mumps virus in rhesus monkeys. J Infect Dis 1979; 139: 324-328.
93. Rubin SA, Pletnikov M, Carbone KM. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. J Virol 1998; 72: 8037-8042.
94. Timmons GD, Johnson KP. Aqueductal stenosis and hydrocephalus after mumps encephalitis. N Engl J Med 1970; 283: 1505-1507.
95. Pongener I, Nandan D, Bhatt GC, et al. Hydrocephalus due to aqueductal stenosis in a case of mumps meningoencephalitis: a rare complication. J Pediatr Neurosci 2013; 8: 179-180.
96. Ogata H, Oka K, Mitsudome A. Hydrocephalus due to acute aque-ductal stenosis following mumps infection: report of a case and review of the literature. Brain Dev 1992; 14: 417-419.
97. Lahat E, Aladjem M, Schiffer J, et al. Hydrocephalus duetobilateral obstruction of the foramen of Monro: a possible late complication of mumps encephalitis. Clin Neurol Neurosurg 1993; 95: 151-154.
98. Tastan Y, Cam H, Yilmaz I, et al. Reversible acute tetraventricular hydrocephalus complicating possible mumps meningoencephalitis. Pe d i atr Int 2007; 49: 100-102.
99. Herndon RM, Johnson RT, Davis LE, et al. Ependymitis in mumps virus meningitis. Electron microscopical studies of cerebrospinal fuid. Arch Neurol 1974; 30: 475-479.
100. Johnson KP, Johnson RT. Granular ependymitis. Occurrence in myxovirus infected rodents and prevalence in man. Am J Pathol 1972; 67: 511-526.
101. Takano T, Takikita S, Shimada M. Experimental mumps virus-induced hydrocephalus: viral neurotropism and neuronal maturity. NeuroReport 1999; 10: 2215-2221.
102. Hall R, Richards H. Hearing loss due to mumps. Arch Dis Child 1987; 62: 189-191.
103. Vuori M, Lahikainen EA, Peltonen T. Perceptive deafness in connection with mumps. A study of 298 servicemen suffering from mumps. Acta Otolaryngol 1962; 55: 231-236.
104. Okamoto M, Shitara T, Nakayama M, et al. Sudden deafness accompanied by asymptomatic mumps. Acta Otolaryngol Suppl 1994; 514: 45-48.
105. Bitnun S, Rakover Y, Rosen G. Acute bilateral total deafness complicating mumps. J Laryngol Otol 1986; 100: 943-945.
106. Hashimoto H, Fujioka M, Kinumaki H. An offce-based prospective study of deafness in mumps. Pe d i atr Infect Dis J 2009; 28: 173-175.
107. Lindsay JR, Davey PR, Ward PH. Inner ear pathology in deafness due to mumps. Ann Otol Rhinol Laryngol 1960; 69: 918-935.
108. Everberg G. Deafness following mumps. Acta Otolaryngol 1957; 48: 397-403.
109. Westmore GA, Pickard BH, Stern H. Isolation of mumps virus from the inner ear after sudden deafness. Br Med J 1979; 1: 14-15.
110. Davis LE, Johnson RT. Experimental viral infections of the inner ear. I. Acute infections of the newborn hamster labyrinth. Lab Invest 1976; 34: 349-356.
111. Tanaka K, Fukuda S, Suenaga T, et al. Experimental mumps virus-induced labyrinthitis. Immunohistochemical and ultrastructural studies. Acta Otolaryngol Suppl 1988; 456: 98-105.
112. Mizushima N, Murakami Y. Deafness following mumps: the possible pathogenesis and incidence of deafness. Auris Nasus Larynx 1986; 13(suppl 1): S55-57.
113. Unal M, Katircioglu S, Karatay MC, et al. Sudden total bilateral deafness due to asymptomatic mumps infection. Int J Pediatr Otorhinolaryngol 1998; 45: 167-169.
114. Tsubota M, Shojaku H, Ishimaru H, et al. Mumps virus may damage the vestibular nerve as well as the inner ear. Acta Otolaryngol 2008; 128: 644-647.
115. Hyden D, Odkvist LM, Kylen P. Vestibular symptoms in mumps deafness. Acta Otolaryngol Suppl 1979; 360: 182-183.
116. Arita M, Ueno Y, Masuyama Y. Complete heart block in mumps myocarditis. Br Heart J 1981; 46: 342-344.
117. Brown NJ, Richmond SJ. Fatal mumps myocarditis in an 8-month-old child. Br Med J 1980; 281: 356-357.
118. Ni J, Bowles NE, Kim YH, et al. Viral infection of the myocardium in endocardial fbroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation 1997; 95: 133-139.
119. Roberts WC, Fox SM, III. Mumps of the heart. Clinical and pathologic features. Circulation 1965; 32: 342-345.
120. Chaudary S, Jaski BE. Fulminant mumps myocarditis. Ann Intern Med 1989; 110: 569-570.
121. Cohen HA, Ashkenazi A, Nussinovitch M, et al. Mumps-associated acute cerebellar ataxia. Am J Dis Child 1992; 146: 930-931.
122. Nussinovitch M, Prais D, Volovitz B, et al. Post-infectious acute cerebellar ataxia in children. Clin Pe d i atr (Philadelphia) 2003; 42: 581-584.
123. Bansal R, Kalita J, Misra UK, et al. Myelitis: a rare presentation of mumps. Pe di atr Neurosurg 1998; 28: 204-206.
124. Gibbons JL, Miller HG, Stanton JB. Para-infectious encephalomyelitis and related syndromes; a critical review of the neurological complications of certain specifc fevers. Q J Med 1956; 25: 427-505.
125. Ghosh S. Guillain-Barre syndrome complicating mumps. Lancet 1967; 1: 895.
126. Kilham L, Levens J, Enders JF. Nonparalytic poliomyelitis and mumps meningoencephalitis. Differential diagnosis. J Am Med Assoc 1949; 140: 934-936.
127. Johnstone JA, Ross CA, Dunn M. Meningitis and encephalitis associated with mumps infection. A 10-year survey. Arch Dis Child 1972; 47: 647-651.
128. Gordon SC, Lauter CB. Mumps arthritis: a review of the literature. Rev Infect Dis 1984; 6: 338-344.
129. Harel L, Amir J, Reish O, et al. Mumps arthritis in children. Pe d i atr Infect Dis J 1990; 9: 928-929.
130. Mulaosmanovic V, Sakic M, Ferhatovic M. [Secondary autoimmune haemolytic anaemia caused by epidemic parotitis virus]. Med Arh 2002; 56: 46-47.
131. O'Brien PK, Smith DS, Galpin OP. Acute pancreatitis and haemolytic anaemia associated with mumps-virus infection. Br Med J 1965; 2: 1529.
132. Eylan E, Zmucky R, Sheba C. Mumps virus and subacute thyroidi-tis; evidence of a causal association. Lancet 1957; 272: 1062-1063.
133. Parmar RC, Bavdekar SB, Sahu DR, et al. Thyroiditis as a presenting feature of mumps. Pe d i atr Infect Dis J 2001; 20: 637-638.
134. Famma PG, Paton WB, Bostock MI. Thrombocytopenic purpura complicating mumps. Br Med J 1964; 2: 1244.
135. Nasab AR. Thrombocytopenic purpura as a complication of mumps. Clin Pe d i atr (Philadelphia) 1971; 10: 420-421.
136. Brent AJ, Hull R, Jeffery KJ, et al. Acute cholecystitis complicating mumps. Clin Infect Dis 2006; 42: 302-303.
137. Warren WR. Hepatitis complicating mumps. Arch Intern Med 1956; 98: 525-528.
138. Ando K, Ishihara M, Kusumoto Y, et al. A case of corneal endothe-liitis with mumps virus RNA in aqueous humor detected by RT-PCR. Ocul Immunol Infamm 2013; 21: 150-152.
139. Khubchandani R, Rane T, Agarwal P, et al. Bilateral neuroretinitis associated with mumps. Arch Neurol 2002; 59: 1633-1636.
140. Singh K, Sodhi PK. Mumps-induced corneal endotheliitis. Cornea 2004; 23: 400-402.
141. St.Geme JW Jr, Peralta H, Van Pelt LF. Intrauterine infection of the rhesus monkey with mumps virus: abbreviated viral replication in the immature fetus as an explanation for split immunologic recognition after birth. J Infect Dis 1972; 126: 249-256.
142. Kurtz JB, Tomlinson AH, Pearson J. Mumps virus isolated from a fetus. Br Med J (Clin Res Ed) 1982; 284: 471.
143. Ylinen O, Jarniven PA. Parotitis during pregnancy. Acta Obstet Gynecol Scand 1953; 32: 121-132.
144. Yamauchi T, Wilson C, St.Geme JW Jr. Transmission of live, attenuated mumps virus to the human placenta. N Engl J Med 1974; 290: 710-712.
145. Garcia AG, Pereira JM, Vidigal N, et al. Intrauterine infection with mumps virus. Obstet Gynecol 1980; 56: 756-759.
146. Jones JF, Ray CG, Fulginiti VA. Perinatal mumps infection. J Pe d i atr 1980; 96: 912-914.
147. Kilham L. Mumps virus in human milk and in milk of infected monkey. J Am Med Assoc 1951; 146: 1231-1232.
148. Lacour M, Maherzi M, Vienny H, et al. Thrombocytopenia in a case of neonatal mumps infection: evidence for further clinical presentations. Eur J Pediatr 1993; 152: 739-741.
149. Siegel M. Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study. J Am Med Assoc 1973; 226: 1521-1524.
150. Centers for Disease Control and Prevention. Mumps surveillance report. Morbid Mortal Weekly Rep 1972; 21: 1-12.
151. Modlin JF, Orenstein WA, Brandling-Bennett AD. Current status of mumps in the United States. J Infect Dis 1975; 132: 106-109.
152. Ennis FA, Hopps HE, Douglas RD, et al. Hydrocephalus in hamsters: induction by natural and attenuated mumps viruses. J Infect Dis 1969; 119: 75-79.
153. McCarthy M, Jubelt B, Fay DB, et al. Comparative studies of fve strains of mumps virus in vitro and in neonatal hamsters: evaluation of growth, cytopathogenicity, and neurovirulence. J Med Virol 1980; 5: 1-15.
154. Kilham L, Margolis G. Induction of congenital hydrocephalus in hamsters with attenuated and natural strains of mumps virus. J Infect Dis 1975; 132: 462-466.
155. Wolinsky JS, Stroop WG. Virulence and persistence of three prototype strains of mumps virus in newborn hamsters. Arch Virol 1978; 57: 355-359.
156. Buynak EB, Hilleman MR. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med 1966; 123: 768-775.
157. Rozina EE, Hilgenfeldt M. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys. Acta Vi ro l 1985; 29: 225-230.
158. Afzal MA, Marsden S, Hull RM, et al. Evaluation of the neurovirulence test for mumps vaccines. Biologicals 1999; 27: 43-49.
159. Xu P, Huang Z, Gao X, et al. Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate. J Virol 2013; 87: 8158-8168.
160. Tsurudome M, Yamada A, Hishiyama M, et al. Replication of mumps virus in mouse: transient replication in lung and potential of systemic infection. Arch Virol 1987; 97: 167-179.
161. Kristensson K, Orvell C, Malm G, et al. Mumps virus infection of the developing mouse brain-appearance of structural virus proteins demonstrated with monoclonal antibodies. J Neuropathol Exp Neurol 1984; 43: 131-140.
162. Hayashi K, Ross ME, Notkins AL. Persistence of mumps viral antigens in mouse brain. Jpn J Exp Med 1976; 46: 197-200.
163. Overman JR, Peers JH, Kilham L. Pathology of mumps virus meningoencephalitis in mice and hamsters. Arch Pathol 1953; 55: 457-465.
164. Parker L, Gilliland SM, Minor P, et al. Assessment of the ferret as an in vivo model for mumps virus infection. J Gen Vi ro l 2013; 94: 1200-1205.
165. Rubin SA, Pletnikov M, Taffs R, et al. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Vi ro l 2000; 74: 5382-5384.
166. Lemon K, Rima BK, McQuaid S, et al. The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J Virol 2007; 81: 8293-8302.
167. Sauder CJ, Zhang CX, Ngo L, et al. Gene-specifc contributions to mumps virus neurovirulence and neuroattenuation. J Virol 2011; 85: 7059-7069.
168. Xu P, Li Z, Sun D, et al. Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to defne the role of the SH ORF in the pathogenesis of mumps virus. Vi ro logy 2011; 417: 126-136.
169. Ludlow M, McQuaid S, Milner D, de Swart RL, Duprex WP. Pathological consequences of systemic measles virus infection. J Pathol 2015; 235: 253-265.